What Triggered The Steepest Market Fall In Six Months?

Why Did Markets Face Their Steepest Fall In Six Months?

The Indian equity market had a turbulent week, witnessing its sharpest decline in nearly half a year. Benchmark indices Sensex and Nifty fell close to 3% each, while Nifty Bank dropped by around 2%. The weakness was broad-based, with all sectoral indices ending in the red. IT stocks led the rout, followed by Pharma, which bore the brunt of recent tariff news from the US.

About This Week’s Market Mood

Markets were under constant pressure for six consecutive sessions, closing each day lower. The Nifty slipped below the crucial 24,700 level, dragged down by IT and Pharma. Broader indices performed even worse, with midcaps falling by nearly 1,200 points in a single week.

This sharp correction highlights investor concerns around external factors, including Donald Trump’s 100% tariffs on US pharma imports and global technology demand uncertainties. Domestic triggers such as stretched valuations and profit-taking also added to the weakness.

How IT Stocks Got Hammered

The IT index registered its worst weekly performance in six months. TCS alone fell 9%, marking its steepest weekly decline in more than five years. Other IT majors like Infosys, HCL Tech, and Wipro also tumbled. Mid-tier IT was hit harder, with Coforge dropping 15%.

Weak earnings visibility, rising concerns over demand slowdown in the US and Europe, and adverse currency movements weighed heavily on IT stocks. Analysts believe that while IT may stabilize long term, volatility is expected to persist in the near term.

Why Pharma Took A Knock

The Nifty Pharma index fell to its one-month low, after US President Donald Trump’s announcement of 100% tariffs on patented and branded drugs. While generics remain mostly insulated, investor sentiment soured across the sector.

Sun Pharma, Dr. Reddy’s, and Cipla all declined, reflecting fears of further scrutiny in exports. Market participants remain cautious, waiting for clarity on how these tariffs will be implemented and whether they could spill over into the generic space.

For traders tracking volatility, today’s perspective may help 👉 Nifty Tip | BankNifty Tip.

Broader Market & Midcap Pain

Midcaps and smallcaps saw sharper declines than largecaps. The Midcap index dropped 1,177 points to 56,379. Many stocks that had run up significantly in recent months corrected sharply, indicating profit-booking by institutional investors.

Sectors like realty, PSU banks, and consumer durables were not spared either, reflecting the broad-based nature of the fall. Investors should be cautious in chasing momentum-heavy stocks, as corrections in overbought counters may continue.

Investor Takeaway

The week’s fall was a reminder that markets do not move in a straight line. IT and Pharma bore the brunt of global headwinds, while midcaps showed how quickly gains can be erased when sentiment turns. Investors should focus on quality stocks, avoid chasing rallies, and keep liquidity handy for opportunities during corrections.

Explore more free market insights at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.

SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment advisor before making any investment decisions. The views expressed are general in nature and may not suit individual investment objectives or financial situations.

Market crash, Sensex fall, Nifty correction, IT stocks down, TCS drop, Coforge crash, Pharma index low, Trump pharma tariffs, midcap correction, Indian stock market news